The Scheele Symposium 2025Lipid nanoparticles - revolutionizing drug delivery
Welcome to the Scheele Symposium in honour of the 2025 Scheele award laureate, Professor Pieter Cullis.
The symposium focuses on various aspects of his research which spans over several decades and has had a significant impact on both the scientific community and patients.
Overall, the symposium in honour of Professor Pieter Cullis work promises to be a stimulating and informative event that highlights the remarkable achievements of one of the leading figures in groundbreaking drug delivery systems and offers an opportunity for researchers to engage in meaningful discussions and collaborations. Drug delivery of new drug modalities using lipid nanoparticles within several different therapeutical areas will be highlighted during the day.
Confirmed speakers
Pieter Cullis, The University of British Colombia, Canada
Hanna Barriga, KTH Royal Institute of Technology, Stockholm
Katarina Edwards, Uppsala University
Margaret Holme, Chalmers University of Technology, Gothenburg
Lennart Lindfors, AstraZeneca, Gothenburg
Roy van der Meel, Eindhoven University of Technology, Netherlands
Randi Nordström, RISE Research Institutes of Sweden
Björn Pilebro, Umeå University
Federica Sebastiani, University of Copenhagen
Program
Participation fee
The early bird fee for Industry delegates is SEK 3800, for Academy delegates SEK 2500 and for members in Apotekarsocieteten SEK 3100. All fees are excl. VAT.
For registrations made after October 6 an additional 1000 SEK will be added on all fees.
There will be scholarships available for participation in The Scheele Symposium, more information and application here https://www.apotekarsocieteten.se/en/scholarships-and-prizes/
The scholarships for the symposium will be announced in late August.
Time and Venue
The Scheele symposium takes place at Svenska Läkaresällskapet in central Stockholm. The symposium starts at 09.00 and ends at 17.00 hrs.
Address – Svenska Läkaresällskapet: Klara Östra Kyrkogata 10, Stockholm, Phone: +46 8 440 88 60.
Scientific Organising Committee
Mikael Hedeland, Uppsala University
Suzanne Iverson, Toxicology Knowledge Team Sweden
Sofia Mattsson, Umeå University
Anja Sandström, Uppsala University
Per Wessman, Novavax
Lisa Bandholtz, Apotekarsocieteten
About the award winner
The Scheele-award 2025 prize-winner is Professor Pieter Cullis, The University of British Colombia, Canada
Professor Cullis is a pioneer in the design, development and optimization of lipid nanoparticles (LNPs) for drug delivery. This fundamental research has enabled the translation of mRNA therapy from a theoretical concept into one of the most effective and scalable medical interventions in modern history. Professor Cullis’ innovations have dramatically enhanced the stability, efficiency, and targeting of mRNA and other nucleic acid-based drugs, contributing to the rapid deployment of mRNA-based vaccines during the global pandemic. Besides vaccines and gene therapy, the LNP technology has also been applied in anticancer medicines. His work continues to influence and inspire ongoing research in nanomedicine, with profound implications for current and future therapies ranging from small molecules to new modalities.